News

PSTI

3 Biotechs Getting a Second Chance After Failed Trials

The Life Sciences Report | Equities.com |

These names have been wrecked and left for dead, but could still have a second act in them.


Why Japan is Crucial to the Future of Stem Cell Research

The Life Sciences Report | Equities.com |

Last year, Japan rolled out the red carpet for cell therapy developers with new legislation designed to expedite development of regenerative medicine solutions for all manner of disease. In this


Biotech Investors Need to Focus on Catalysts

The Life Sciences Report | Equities.com |

When progress is made in drug development, value is created. Investors recognize that progress by purchasing shares in companies when milestones—which act as catalysts—are met. The


5 Micro and Small-Cap Biotechs Developing Stem Cell Treatments

Michael Teague | Equities.com |

Stem cells have once again flitted through the news cycle, this time as a result of a new and growing industry that has arisen around the use of adult stem cells in cosmetic treatments that


Equities Sector Coverage: Markets Get a Boost from Bernanke

Sector Recap | Equities.com |

Initial Jobless Claims rose more than expected to 382,000 well above the 350,000 recessionary threshold. The Producer Price Index rose to 1.7% in August boosted by energy costs. Core PPI was up


Equities Sector Coverage: Stocks Continue to Break Lower

Sector Recap | Equities.com |

CPI was flat in April, up 0.2% excluding food and energy. Retail Sales rose just 0.1% in April with and without autos. After a Dip in April, the NAHB Home Builder Index jumped 5 points to 29 in


Are We...........Or Aren't We ?

George Brooks | Equities.com |

Brooksie's Daily Stock Market blog  - An edge before the openWednesday, August 17, 2011      9:11 am EDTDJIA:  11,405.93     S&P 500: 1192.76Not a bad performance. The market


Watchlist

Symbol Last Price Change % Change
AAPL

     
AMZN

     
HD

     
JPM

     
IBM

     

INTERVIEW: CEO Jorge Fernandez - iBlades

Equities.com's Sam Mitchell interview iBlades CEO, Jorge Fernandez